CD4 and familial dilated cardiomyopathy: Together, the results indicated that treatment with hUCMSCs, particularly with IDO-OE cells, modulated the frequency of systemic CD4+ T cell subsets by inhibiting pro-inflammatory Th1 and Th17 responses, but enhancing anti-inflammatory Th2 and Treg responses in DCM rats.